XIMANDER Trademark

Trademark Overview

On Friday, May 28, 2010, a trademark application was filed for XIMANDER with the United States Patent and Trademark Office. The USPTO has given the XIMANDER trademark a serial number of 85050329. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 21, 2014. This trademark is owned by Glaxo Group Limited. The XIMANDER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
ximander

General Information

Serial Number85050329
Word MarkXIMANDER
Filing DateFriday, May 28, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 21, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 2, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, July 21, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 21, 2014ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 14, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 13, 2013EXTENSION 5 GRANTED
Monday, December 9, 2013EXTENSION 5 FILED
Monday, December 9, 2013TEAS EXTENSION RECEIVED
Tuesday, June 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2013EXTENSION 4 GRANTED
Friday, May 31, 2013EXTENSION 4 FILED
Friday, May 31, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 6, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 5, 2012EXTENSION 3 GRANTED
Monday, December 3, 2012EXTENSION 3 FILED
Monday, December 3, 2012TEAS EXTENSION RECEIVED
Tuesday, July 3, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 2, 2012EXTENSION 2 GRANTED
Tuesday, June 12, 2012EXTENSION 2 FILED
Friday, June 29, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 12, 2012TEAS EXTENSION RECEIVED
Thursday, December 1, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 29, 2011EXTENSION 1 GRANTED
Tuesday, November 29, 2011EXTENSION 1 FILED
Tuesday, November 29, 2011TEAS EXTENSION RECEIVED
Tuesday, November 29, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 14, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 19, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2011PUBLISHED FOR OPPOSITION
Wednesday, March 16, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 16, 2011ASSIGNED TO LIE
Monday, February 28, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 26, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 26, 2010LETTER OF SUSPENSION E-MAILED
Thursday, August 26, 2010SUSPENSION LETTER WRITTEN
Thursday, August 26, 2010ASSIGNED TO EXAMINER
Wednesday, June 2, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 1, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

ximander pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic